Shares in Edwards Lifesciences Corp. rose 6.3% in after-hours trading after posting second quarter earnings that beat analysts’ expectations.
The medical device maker reported that second-quarter revenue grew 12% to $1.53 billion, surpassing estimates of $1.49 billion. Edwards also reported adjusted earnings per share of 67 cents, above the 62 cents expected by analysts.
“We are pleased to report strong second quarter results that delivered double-digit sales growth,” Edwards Chief Executive Bernard Zovighian said in a statement.
Edwards now expects full-year sales to grow by 9% to 10%, raising it from the previous 8% to 10%.
Its shares increased 6.3% in after-hours trading to $80.55 and a $44.5 billion market cap.
